Nanobiotix S.A.
NBTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001760854
No open-market purchases or sales by Nanobiotix S.A. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $218.4M in total; no superinvestor holds it.
Other share classesNNBXF
13F holders, Q4 2023
Institutional positions in Nanobiotix S.A. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 12
- +3 vs. Q3 2023
- Shares held
- 9.27M
- +4.80M (+107.5%) vs. Q3 2023
- Total value
- $67.5M
- +$28.4M (+72.6%) vs. Q3 2023
- New holders
- 5
- 2 more added
- Sold out
- 2
- 3 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NBTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 19 | $218.4M |
| Q1 2026 | 15 | $175.9M |
| Q4 2025 | 14 | $131.8M |
| Q3 2025 | 11 | $106.6M |
| Q2 2025 | 10 | $25.6M |
| Q1 2025 | 12 | $20.6M |
| Q4 2024 | 18 | $17.4M |
| Q3 2024 | 10 | $36.9M |
| Q2 2024 | 12 | $46.5M |
| Q1 2024 | 12 | $59.7M |
| Q4 2023 | 12 | $67.5M |
| Q3 2023 | 9 | $39.1M |
| Q2 2023 | 5 | $17.7M |
| Q1 2023 | 4 | $12.4M |
| Q4 2022 | 5 | $12.2M |
| Q3 2022 | 5 | $12.2M |
| Q2 2022 | 6 | $13.3M |
| Q1 2022 | 6 | $26.0M |
| Q4 2021 | 7 | $28.8M |
| Q3 2021 | 9 | $46.5M |
| Q2 2021 | 10 | $66.9M |
| Q1 2021 | 10 | $73.2M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Nanobiotix S.A.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Johnson & Johnson | 5,623,816 | $40.9M | 0.93% | +4,664,179+486.0% | Added |
| Baillie Gifford & Co | 2,869,030 | $20.9M | 0.02% | +932,835+48.2% | Added |
| Perceptive Advisors LLC | 555,066 | $4.04M | 0.09% | 00.0% | Unchanged |
| BlackRock Inc. | 218,515 | $1.59M | 0.00% | +218,515 | New |
| UBS Group AG | 3,100 | $22.6K | 0.00% | −706−18.5% | Reduced |
| Citigroup Inc | 635 | $4.62K | 0.00% | +635 | New |
| Qube Research & Technologies Ltd | 343 | $2.50K | 0.00% | −357−51.0% | Reduced |
| Morgan Stanley | 302 | $2.20K | 0.00% | −1,398−82.2% | Reduced |
| Royal Bank of Canada | 305 | $2.00K | 0.00% | +305 | New |
| GAMMA Investing LLC | 175 | $1.33K | 0.00% | +175 | New |
| Bank of America Corp | 141 | $1.03K | 0.00% | +141 | New |
| Rhumbline Advisers | 33 | $240 | 0.00% | 00.0% | Unchanged |
| Artal Group S.A. | 0 | $0 | 0.00% | −1,000,000−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −11,201−100.0% | Sold out |